Drug Shortage Report for OZEMPIC

Last updated on 2024-02-17 History
Report ID 208495
Drug Identification Number 02471477
Brand name OZEMPIC
Common or Proper name OZEMPIC 0.25MG/0.5MG
Company Name NOVO NORDISK CANADA INC
Market Status MARKETED
Active Ingredient(s) SEMAGLUTIDE
Strength(s) 1.34MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 1
ATC code A10BJ
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date 2023-11-15
Actual start date
Estimated end date 2024-02-15
Actual end date 2024-02-16
Shortage status Resolved
Updated date 2024-02-17
Company comments Health Canada expedited the approval of a new 3 mL Ozempic® low dose (0.25mg/0.5mg) pen to stabilize Ozempic® low dose (0.25mg/0.5mg) supply. The shortage of the Ozempic® (0.25mg/0.5mg) pen listed on the Drug Shortages webpage applies only to the previous 1.5mL pen and will be maintained until the transition to the new 3mL pen is complete.
Health Canada comments
Tier 3 Status Yes
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-02-17 English Compare
v13 2024-02-16 French Compare
v12 2024-02-16 English Compare
v11 2024-02-08 French Compare
v10 2024-02-08 English Compare
v9 2024-01-17 French Compare
v8 2024-01-17 English Compare
v7 2024-01-17 French Compare
v6 2024-01-17 English Compare
v5 2023-12-12 English Compare
v4 2023-11-16 English Compare
v3 2023-10-30 French Compare
v2 2023-10-30 English Compare
v1 2023-10-30 English Compare

Showing 1 to 14 of 14